← Back to headlines
Madrigal Pharmaceuticals' MASH Strategy Reinforced by Rezdiffra Sales and Pipeline
Madrigal Pharmaceuticals' strategy for MASH is being strengthened by the sales growth of Rezdiffra and the expansion of its pipeline.
6 May, 14:46 — 6 May, 14:46
Sources
Showing 1 of 1 sources
